Pharmaceutical Industries Ltd.
Menu
Health Products
WCAG 2.0
Print

TARO-SITAGLIPTIN FUMARATE, Tablets
« Back to list view

Product Information

  • DIN:
    02531631
  • Active Ingredients :
    sitagliptin fumarate
  • Innovator Name:
    JANUVIA®
  • Category:
    Dipeptidyl peptidase 4 (DPP-4) inhibitors
  • Dosage form:
    Tablets
  • Strength:
    25 mg
  • Route of Administration:
    Oral
  • Package size:
    90 Bottle
  • UPC Code:
    063691101623
  • Description :
    Light pink colour, round, film-coated tablets, debossed with “F1” on one side and plain on the other side.
  • Non-medicinal ingredients :
    Calcium hydrogen phosphate, crospovidone, glycerol dibehenate, hydrogenated castor oil, hypromellose, ferric oxide red, ferric oxide yellow, magnesium stearate, polyethylene glycol (macrogol), talc and titanium dioxide.
TARO-SITAGLIPTIN FUMARATE, Tablets

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02531658
  • Active Ingredients :
    sitagliptin fumarate
  • Innovator Name:
    JANUVIA®
  • Category:
    Dipeptidyl peptidase 4 (DPP-4) inhibitors
  • Dosage form:
    Tablets
  • Strength:
    50 mg
  • Route of Administration:
    Oral
  • Package size:
    90 Bottle
  • UPC Code:
    063691101654
  • Description :
    Light beige colour, round, film-coated tablets, debossed with “F2” on one side and plain on the other side.
  • Non-medicinal ingredients :
    Calcium hydrogen phosphate, crospovidone, glycerol dibehenate, hydrogenated castor oil, hypromellose, ferric oxide red, ferric oxide yellow, magnesium stearate, polyethylene glycol (macrogol), talc and titanium dioxide.
TARO-SITAGLIPTIN FUMARATE, Tablets

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02531666
  • Active Ingredients :
    sitagliptin fumarate
  • Innovator Name:
    JANUVIA®
  • Category:
    Dipeptidyl peptidase 4 (DPP-4) inhibitors
  • Dosage form:
    Tablets
  • Strength:
    100 mg
  • Route of Administration:
    Oral
  • Package size:
    90 Bottle
  • UPC Code:
    063691101685
  • Description :
    Beige colour, round, film-coated tablets, debossed with “F3” on one side and plain on the other side.
  • Non-medicinal ingredients :
    Calcium hydrogen phosphate, crospovidone, glycerol dibehenate, hydrogenated castor oil, hypromellose, ferric oxide red, ferric oxide yellow, magnesium stearate, polyethylene glycol (macrogol), talc and titanium dioxide
TARO-SITAGLIPTIN FUMARATE, Tablets

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Health Products
WCAG 2.0

Copyright © Taro Pharmaceutical Industries Ltd.

Privacy Statement | Terms of Use | Safe Harbor Statement